Farré M - Search Results

1

Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.

Torrens M, Fonseca F, Mateu G, Farré M. Torrens M, et al. Among authors: farre m. Drug Alcohol Depend. 2005 Apr 4;78(1):1-22. doi: 10.1016/j.drugalcdep.2004.09.004. Epub 2004 Nov 11. Drug Alcohol Depend. 2005. PMID: 15769553 Review.

2

3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.

Hernández-López C, Farré M, Roset PN, Menoyo E, Pizarro N, Ortuño J, Torrens M, Camí J, de La Torre R. Hernández-López C, et al. Among authors: farre m. J Pharmacol Exp Ther. 2002 Jan;300(1):236-44. doi: 10.1124/jpet.300.1.236. J Pharmacol Exp Ther. 2002. PMID: 11752122 Clinical Trial.

3

Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis.

Farré M, Mas A, Torrens M, Moreno V, Camí J. Farré M, et al. Drug Alcohol Depend. 2002 Feb 1;65(3):283-90. doi: 10.1016/s0376-8716(01)00171-5. Drug Alcohol Depend. 2002. PMID: 11841899

4

Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics.

Farré M, de la Torre R, Mathúna BO, Roset PN, Peiró AM, Torrens M, Ortuño J, Pujadas M, Camí J. Farré M, et al. Psychopharmacology (Berl). 2004 May;173(3-4):364-75. doi: 10.1007/s00213-004-1789-7. Epub 2004 Apr 8. Psychopharmacology (Berl). 2004. PMID: 15071716 Clinical Trial.

5

Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition.

de la Torre R, Farré M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Camí J. de la Torre R, et al. Among authors: farre m. Ther Drug Monit. 2004 Apr;26(2):137-44. doi: 10.1097/00007691-200404000-00009. Ther Drug Monit. 2004. PMID: 15228154 Review.

6

[Club drugs: old medicines as new party drugs].

Abanades S, Peiró AM, Farré M. Abanades S, et al. Among authors: farre m. Med Clin (Barc). 2004 Sep 11;123(8):305-11. doi: 10.1016/s0025-7753(04)74499-1. Med Clin (Barc). 2004. PMID: 15373979 Review. Spanish.

7

Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe.

Segura M, Farré M, Pichini S, Peiró AM, Roset PN, Ramírez A, Ortuño J, Pacifici R, Zuccaro P, Segura J, de la Torre R. Segura M, et al. Among authors: farre m. Clin Pharmacokinet. 2005;44(6):649-60. doi: 10.2165/00003088-200544060-00006. Clin Pharmacokinet. 2005. PMID: 15910012 Clinical Trial.

8

Areca-nut abuse and neonatal withdrawal syndrome.

López-Vilchez MA, Seidel V, Farré M, García-Algar O, Pichini S, Mur A. López-Vilchez MA, et al. Among authors: farre m. Pediatrics. 2006 Jan;117(1):e129-31. doi: 10.1542/peds.2005-0281. Epub 2005 Dec 15. Pediatrics. 2006. PMID: 16361222

9

A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials.

Macedo A, Farré M, Baños JE. Macedo A, et al. Among authors: farre m. Eur J Clin Pharmacol. 2006 Mar;62(3):161-72. doi: 10.1007/s00228-005-0088-5. Epub 2006 Jan 10. Eur J Clin Pharmacol. 2006. PMID: 16402240

10

Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics.

Abanades S, Farré M, Segura M, Pichini S, Barral D, Pacifici R, Pellegrini M, Fonseca F, Langohr K, De La Torre R. Abanades S, et al. Among authors: farre m. Ann N Y Acad Sci. 2006 Aug;1074:559-76. doi: 10.1196/annals.1369.065. Ann N Y Acad Sci. 2006. PMID: 17105953 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results